Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD

Blood (2009) 114 (22): 2085.

https://doi.org/10.1182/blood.V114.22.2085.2085

Published: 2009

Journal Articles

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, Katherine L. B. Borden

Blood (2009) 114 (2): 257–260.

https://doi.org/10.1182/blood-2009-02-205153

Published: 2009

Includes: Supplemental data

Journal Articles

Ectopic Expression of Mutated HOXB4 Proteins with Increased Intracellular Stability Affects Both Long and Short Term Hematopoietic Reconstitution.

Stephanie Beauchemin, Gorazd Krosl, Nathalie Beslu, Jana Krosl, Guy Sauvageau, Denis-Claude Roy

Blood (2006) 108 (11): 3183.

https://doi.org/10.1182/blood.V108.11.3183.3183

Published: 2006

Journal Articles

Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation

Aline Mamo, Jana Krosl, Evert Kroon, Janet Bijl, Alexander Thompson, Nadine Mayotte, Simon Girard, Richard Bisaillon, Nathalie Beslu, Mark Featherstone, Guy Sauvageau

Blood (2006) 108 (2): 622–629.

https://doi.org/10.1182/blood-2005-06-2244

Published: 2006

Includes: Supplemental data

Journal Articles

Molecular interactions involved in HOXB4-induced activation of HSC self-renewal

Nathalie Beslu, Jana Krosl, Mélanie Laurin, Nadine Mayotte, Keith R. Humphries, Guy Sauvageau

Blood (2004) 104 (8): 2307–2314.

https://doi.org/10.1182/blood-2004-04-1653

Published: 2004

NARROW

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Ectopic Expression of Mutated HOXB4 Proteins with Increased Intracellular Stability Affects Both Long and Short Term Hematopoietic Reconstitution.

Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation

Molecular interactions involved in HOXB4-induced activation of HSC self-renewal

Email alerts

ASH Publications

American Society of Hematology

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Ectopic Expression of Mutated HOXB4 Proteins with Increased Intracellular Stability Affects Both Long and Short Term Hematopoietic Reconstitution.

Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation

Molecular interactions involved in HOXB4-induced activation of HSC self-renewal

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only